Gene Therapy Alters Immune Cells For Treatment Of Advanced Melanoma
SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma
Long-Term Remissions Shown With Chemo Plus Radiation
Raloxifene Protects Women At High or Low Risk of Disease
Study Needs 23,000 Women Whose Sisters Have Cancer
Tamoxifen: No Mortality Benefit For Most “High Risk” Women
Breast Density As Important As Age In Determining Risk
Ovariectomy Without HRT Increases Death Rate
NCI-Approved Clinical Trials
Trending Stories
- Karen Knudsen to leave ACS
- A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies - Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Mace Rothenberg’s museum will tell the stories behind breakthroughs in medicine
- Melanoma investigators invite FDA to publicly discuss approval endpoints and crossover design
The agency accepts the invitation